{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T23:54:38Z","timestamp":1794959678875,"version":"4.9.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T00:00:00Z","timestamp":1674086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T00:00:00Z","timestamp":1674086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Royal Victoria Eye and Ear Hospital Research Foundation and the Irish College of Ophthalmologists \/Novartis Eye Research Bursary supported this work"},{"name":"The Royal Victoria Eye and Ear Hospital Research Foundation Research Bursary The Irish College of Ophthalmologists \/Novartis Eye Research Bursary"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To quantify the impact of dry eye disease (DED) on health and vision related quality of life (HR-QOL, VR-QOL) in patients with Primary Sj\u00f6gren\u2019s Syndrome (pSS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Thirty-four participants with a confirmed diagnosis of pSS as per the 2016 ACR EULAR criteria participated. Main outcome measures included ocular surface parameters and HR-QOL and VR-QOL questionnaires. Clinical examination included visual acuity, Schirmer I testing, ocular surface staining (OSS) and measurement of tear film breakup time. The questionnaires included Ocular Surface Disease Index, National Eye Institute Visual Function Questionnaire-25, Short Form-36 (SF-36) and EULAR Sjogren\u2019s Syndrome Patient Reported Index.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Despite the majority of participants (28 female, 6 male, mean age 61.3 years) having attained LogMAR 0.3 or better visual acuity, participants scored low on VR-QOL measures, representing DED related fluctuation in functional vision. All participants suffered from moderate to severe DED. OSS did not correlate with DED symptoms or QOL parameters. Lubricant usage and symptom severity had a statistically moderate to strong negative correlation with VR-QOL and HR-QOL. This was most evident in relation to physical and physiological wellbeing. Compared with normative data, participants had a lower HR-QOL in all scales of the SF-36 ((MD\u2009=\u20099.91\u2009\u00b1\u20095.16); t(7)\u2009=\u20095.43,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Participants with pSS have a lower perceived QOL especially in relation to physical and mental wellbeing, correlating to severity of DED symptoms and treatment burden. Clinical signs do not align with symptoms. Therefore, clinicians should remain cognisant, adjusting treatment in accordance with patient reported perceptions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41433-023-02386-2","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T02:04:40Z","timestamp":1674093880000},"page":"2685-2692","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Relationship between clinical parameters and quality of life in primary Sj\u00f6gren\u2019s Syndrome: a prospective study"],"prefix":"10.1038","volume":"37","author":[{"given":"E.","family":"Greenan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Pilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4247-3952","authenticated-orcid":false,"given":"J.","family":"N\u00ed Gabhann-Dromgoole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2171-0418","authenticated-orcid":false,"given":"C. C.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,19]]},"reference":[{"key":"2386_CR1","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","volume":"15","author":"JP Craig","year":"2017","unstructured":"Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo CK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15:276\u201383.","journal-title":"Ocul Surf"},{"key":"2386_CR2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","volume":"366","author":"RI Fox","year":"2005","unstructured":"Fox RI. Sjogren\u2019s syndrome. Lancet (Lond, Engl). 2005;366:321\u201331.","journal-title":"Lancet (Lond, Engl)"},{"key":"2386_CR3","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.molimm.2003.10.006","volume":"40","author":"M Yamamoto","year":"2004","unstructured":"Yamamoto M, Takeda K, Akira S. TIR domain-containing adaptors define the specificity of TLR signaling. Mol Immunol. 2004;40:861\u20138.","journal-title":"Mol Immunol"},{"key":"2386_CR4","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1046\/j.1365-2796.1996.418817000.x","volume":"239","author":"K Asmussen","year":"1996","unstructured":"Asmussen K, Andersen V, Bendixen G, Schiodt M, Oxholm P. A new model for classification of disease manifestations in primary Sjogren\u2019s syndrome: evaluation in a retrospective long-term study. J Intern Med. 1996;239:475\u201382.","journal-title":"J Intern Med"},{"key":"2386_CR5","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","volume":"15","author":"AJ Bron","year":"2017","unstructured":"Bron AJ, de Paiva CS, Chauhan SK, Bonini S, Gabison EE, Jain S, et al. TFOS DEWS II pathophysiology report. Ocul Surf. 2017;15:438\u2013510.","journal-title":"Ocul Surf"},{"key":"2386_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ajo.2020.03.044","volume":"216","author":"R Dana","year":"2020","unstructured":"Dana R, Meunier J, Markowitz JT, Joseph C, Siffel C. Patient-reported burden of dry eye disease in the United States: results of an online cross-sectional survey. Am J Ophthalmol. 2020;216:7\u201317.","journal-title":"Am J Ophthalmol"},{"key":"2386_CR7","doi-asserted-by":"publisher","first-page":"e039209-e","DOI":"10.1136\/bmjopen-2020-039209","volume":"11","author":"P Hossain","year":"2021","unstructured":"Hossain P, Siffel C, Joseph C, Meunier J, Markowitz JT, Dana R. Patient-reported burden of dry eye disease in the UK: a cross-sectional web-based survey. BMJ Open. 2021;11:e039209-e.","journal-title":"BMJ Open"},{"key":"2386_CR8","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1038\/eye.2016.186","volume":"30","author":"KH Wan","year":"2016","unstructured":"Wan KH, Chen LJ, Young AL. Depression and anxiety in dry eye disease: a systematic review and meta-analysis. Eye (Lond). 2016;30:1558\u201367.","journal-title":"Eye (Lond)"},{"key":"2386_CR9","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jtos.2014.12.001","volume":"13","author":"GN Foulks","year":"2015","unstructured":"Foulks GN, Forstot SL, Donshik PC, Forstot JZ, Goldstein MH, Lemp MA, et al. Clinical guidelines for management of dry eye associated with Sj\u00f6gren disease. Ocul Surf. 2015;13:118\u201332.","journal-title":"Ocul Surf"},{"key":"2386_CR10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/art.39859","volume":"69","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, et al. 2016 American College of Rheumatology\/European League Against Rheumatism Classification Criteria for Primary Sj\u00f6gren\u2019s Syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol. 2017;69:35\u201345.","journal-title":"Arthritis Rheumatol"},{"key":"2386_CR11","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/archopht.118.5.615","volume":"118","author":"RM Schiffman","year":"2000","unstructured":"Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol (Chic, Ill: 1960). 2000;118:615\u201321.","journal-title":"Arch Ophthalmol (Chic, Ill: 1960)"},{"key":"2386_CR12","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1001\/archopht.119.7.1050","volume":"119","author":"CM Mangione","year":"2001","unstructured":"Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol (Chic, Ill: 1960). 2001;119:1050\u20138.","journal-title":"Arch Ophthalmol (Chic, Ill: 1960)"},{"key":"2386_CR13","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1136\/ard.2010.143743","volume":"70","author":"R Seror","year":"2011","unstructured":"Seror R, Ravaud P, Mariette X, Bootsma H, Theander E, Hansen A, et al. EULAR Sjogren\u2019s Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren\u2019s syndrome. Ann Rheum Dis. 2011;70:968\u201372.","journal-title":"Ann Rheum Dis"},{"key":"2386_CR14","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1097\/00006324-199211000-00007","volume":"69","author":"P Cho","year":"1992","unstructured":"Cho P, Brown B, Chan I, Conway R, Yap M. Reliability of the tear break-up time technique of assessing tear stability and the locations of the tear break-up in Hong Kong Chinese. Optom Vis Sci: Off Publ Am Acad Optom. 1992;69:879\u201385.","journal-title":"Optom Vis Sci: Off Publ Am Acad Optom"},{"key":"2386_CR15","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/00003226-200404000-00010","volume":"23","author":"KK Nichols","year":"2004","unstructured":"Nichols KK, Mitchell GL, Zadnik K. The repeatability of clinical measurements of dry eye. Cornea 2004;23:272\u201385.","journal-title":"Cornea"},{"key":"2386_CR16","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1046\/j.1475-1313.1998.00385.x","volume":"18","author":"P Cho","year":"1998","unstructured":"Cho P, Leung L, Lam A, Choi A. Tear break-up time: clinical procedures and their effects. Ophthalmic Physiol Opt J Br Coll Ophthalmic Opt. 1998;18:319\u201324.","journal-title":"Ophthalmic Physiol Opt J Br Coll Ophthalmic Opt"},{"key":"2386_CR17","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/art.22536","volume":"57","author":"V Devauchelle-Pensec","year":"2007","unstructured":"Devauchelle-Pensec V, Pennec Y, Morvan J, Pers JO, Daridon C, Jousse-Joulin S, et al. Improvement of Sjogren\u2019s syndrome after two infusions of rituximab (anti-CD20). Arthritis Rheum. 2007;57:310\u20137.","journal-title":"Arthritis Rheum"},{"key":"2386_CR18","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/eye.1997.161","volume":"11","author":"AJ Bron","year":"1997","unstructured":"Bron AJ. The Doyne Lecture. Reflections on the tears. Eye (Lond, Engl). 1997;11:583\u2013602.","journal-title":"Eye (Lond, Engl)"},{"key":"2386_CR19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/BF03167695","volume":"169","author":"C Blake","year":"2000","unstructured":"Blake C, Codd MB, O\u2019Meara YM. The Short Form 36 (SF-36) Health Survey: normative data for the Irish population. Ir J Med Sci. 2000;169:195\u2013200.","journal-title":"Ir J Med Sci"},{"key":"2386_CR20","unstructured":"Ware JEKM, Keller SD SF-36 Physical and Mental Health Summary Scales: A User\u2019s Manual Boston, MA. Health Assessment Lab, New England Medical Center. 1994."},{"key":"2386_CR21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1159\/000487487","volume":"59","author":"DA Sullivan","year":"2018","unstructured":"Sullivan DA, Dana R, Sullivan RM, Krenzer KL, Sahin A, Arica B, et al. Meibomian gland dysfunction in primary and secondary Sj\u00f6gren syndrome. Ophthalmic Res. 2018;59:193\u2013205.","journal-title":"Ophthalmic Res"},{"key":"2386_CR22","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1038\/s41433-018-0149-5","volume":"32","author":"S Zang","year":"2018","unstructured":"Zang S, Cui Y, Cui Y, Fei W. Meibomian gland dropout in Sj\u00f6gren\u2019s syndrome and non-Sj\u00f6gren\u2019s dry eye patients. Eye. 2018;32:1681\u20137.","journal-title":"Eye"},{"key":"2386_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.optom.2016.06.002","volume":"10","author":"CW McMonnies","year":"2017","unstructured":"McMonnies CW. The potential role of neuropathic mechanisms in dry eye syndromes. J Optom. 2017;10:5\u201313.","journal-title":"J Optom"},{"key":"2386_CR24","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jtos.2017.05.002","volume":"15","author":"C Belmonte","year":"2017","unstructured":"Belmonte C, Nichols JJ, Cox SM, Brock JA, Begley CG, Bereiter DA, et al. TFOS DEWS II pain and sensation report. Ocul Surf. 2017;15:404\u201337.","journal-title":"Ocul Surf"},{"key":"2386_CR25","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1097\/01.ico.0000133997.07144.9e","volume":"23","author":"KK Nichols","year":"2004","unstructured":"Nichols KK, Nichols JJ, Mitchell GL. The lack of association between signs and symptoms in patients with dry eye disease. Cornea. 2004;23:762\u201370.","journal-title":"Cornea"},{"key":"2386_CR26","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/ICU.0b013e32833a8c15","volume":"21","author":"NJ Friedman","year":"2010","unstructured":"Friedman NJ. Impact of dry eye disease and treatment on quality of life. Curr Opin Ophthalmol. 2010;21:310\u20136.","journal-title":"Curr Opin Ophthalmol"},{"key":"2386_CR27","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","volume":"15","author":"F Stapleton","year":"2017","unstructured":"Stapleton F, Alves M, Bunya VY, Jalbert I, Lekhanont K, Malet F, et al. TFOS DEWS II epidemiology report. Ocul Surf. 2017;15:334\u201365.","journal-title":"Ocul Surf"},{"key":"2386_CR28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s40135-013-0009-1","volume":"1","author":"M Uchino","year":"2013","unstructured":"Uchino M, Schaumberg DA. Dry eye disease: impact on quality of life and vision. Curr Ophthalmol Rep. 2013;1:51\u20137.","journal-title":"Curr Ophthalmol Rep"},{"key":"2386_CR29","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1097\/ICO.0000000000000998","volume":"35","author":"S Koh","year":"2016","unstructured":"Koh S. Mechanisms of visual disturbance in dry eye. Cornea. 2016;35:S83\u2013s8.","journal-title":"Cornea"},{"key":"2386_CR30","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1167\/iovs.07-0762","volume":"49","author":"S Koh","year":"2008","unstructured":"Koh S, Maeda N, Hirohara Y, Mihashi T, Bessho K, Hori Y, et al. Serial measurements of higher-order aberrations after blinking in patients with dry eye. Investigative Ophthalmol Vis Sci. 2008;49:133\u20138.","journal-title":"Investigative Ophthalmol Vis Sci"},{"key":"2386_CR31","first-page":"4117","volume":"41","author":"R Tutt","year":"2000","unstructured":"Tutt R, Bradley A, Begley C, Thibos LN. Optical and visual impact of tear break-up in human eyes. Invest Ophthalmol Vis Sci. 2000;41:4117\u201323.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2386_CR32","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0002-9394(01)01365-4","volume":"133","author":"E Goto","year":"2002","unstructured":"Goto E, Yagi Y, Matsumoto Y, Tsubota K. Impaired functional visual acuity of dry eye patients. Am J Ophthalmol. 2002;133:181\u20136.","journal-title":"Am J Ophthalmol"},{"key":"2386_CR33","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/00003226-199807000-00006","volume":"17","author":"M Rolando","year":"1998","unstructured":"Rolando M, Iester M, Macr\u00ed A, Calabria G. Low spatial-contrast sensitivity in dry eyes. Cornea. 1998;17:376\u20139.","journal-title":"Cornea"},{"key":"2386_CR34","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1167\/iovs.03-0915","volume":"46","author":"P Mertzanis","year":"2005","unstructured":"Mertzanis P, Abetz L, Rajagopalan K, Espindle D, Chalmers R, Snyder C, et al. The relative burden of dry eye in patients\u2019 lives: comparisons to a U.S. normative sample. Invest Ophthalmol Vis Sci. 2005;46:46\u201350.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2386_CR35","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ajo.2006.11.060","volume":"143","author":"B Miljanovi\u0107","year":"2007","unstructured":"Miljanovi\u0107 B, Dana R, Sullivan DA, Schaumberg DA. Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol. 2007;143:409\u201315.","journal-title":"Am J Ophthalmol"},{"key":"2386_CR36","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ajo.2006.11.060","volume":"143","author":"B Miljanovic","year":"2007","unstructured":"Miljanovic B, Dana R, Sullivan DA, Schaumberg DA. Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol. 2007;143:409\u201315.","journal-title":"Am J Ophthalmol"},{"key":"2386_CR37","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.ophtha.2012.03.004","volume":"119","author":"A Denoyer","year":"2012","unstructured":"Denoyer A, Rabut G, Baudouin C. Tear film aberration dynamics and vision-related quality of life in patients with dry eye disease. Ophthalmology. 2012;119:1811\u20138.","journal-title":"Ophthalmology"},{"key":"2386_CR38","doi-asserted-by":"publisher","first-page":"e0123299-e","DOI":"10.1371\/journal.pone.0123299","volume":"10","author":"M Kawashima","year":"2015","unstructured":"Kawashima M, Uchino M, Yokoi N, Uchino Y, Dogru M, Komuro A, et al. Associations between subjective happiness and dry eye disease: a new perspective from the Osaka study. PLoS One. 2015;10:e0123299-e.","journal-title":"PLoS One"},{"key":"2386_CR39","doi-asserted-by":"publisher","DOI":"10.1177\/1744806917729306","volume":"13","author":"AE Levitt","year":"2017","unstructured":"Levitt AE, Galor A, Chowdhury AR, Felix ER, Sarantopoulos CD, Zhuang GY, et al. Evidence that dry eye represents a chronic overlapping pain condition. Mol Pain. 2017;13:1744806917729306.","journal-title":"Mol Pain"},{"key":"2386_CR40","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1111\/j.1526-4637.2011.01187.x","volume":"12","author":"PG Fine","year":"2011","unstructured":"Fine PG. Long-term consequences of chronic pain: mounting evidence for pain as a neurological disease and parallels with other chronic disease states. Pain Med (Malden, Mass). 2011;12:996\u20131004.","journal-title":"Pain Med (Malden, Mass)"},{"key":"2386_CR41","doi-asserted-by":"publisher","first-page":"e000649-e","DOI":"10.1136\/bmjophth-2020-000649","volume":"6","author":"G Vakros","year":"2021","unstructured":"Vakros G, Scollo P, Hodson J, Murray PI, Rauz S. Anxiety and depression in inflammatory eye disease: exploring the potential impact of topical treatment frequency as a putative psychometric item. BMJ Open Ophthalmol. 2021;6:e000649-e.","journal-title":"BMJ Open Ophthalmol"},{"key":"2386_CR42","doi-asserted-by":"publisher","first-page":"291","DOI":"10.14219\/jada.archive.2008.0158","volume":"139","author":"CM Stewart","year":"2008","unstructured":"Stewart CM, Berg KM, Cha S, Reeves WH. Salivary dysfunction and quality of life in Sj\u00f6gren syndrome: a critical oral-systemic connection. J Am Dent Assoc (1939). 2008;139:291\u20139. quiz 358-9","journal-title":"J Am Dent Assoc (1939)"},{"key":"2386_CR43","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1093\/rheumatology\/kep141","volume":"48","author":"JM Meijer","year":"2009","unstructured":"Meijer JM, Meiners PM, Huddleston Slater JJ, Spijkervet FK, Kallenberg CG, Vissink A, et al. Health-related quality of life, employment and disability in patients with Sjogren\u2019s syndrome. Rheumatol (Oxf, Engl). 2009;48:1077\u201382.","journal-title":"Rheumatol (Oxf, Engl)"},{"key":"2386_CR44","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1177\/0961203316674819","volume":"26","author":"T Dassouki","year":"2017","unstructured":"Dassouki T, Benatti FB, Pinto AJ, Roschel H, Lima FR, Augusto K, et al. Objectively measured physical activity and its influence on physical capacity and clinical parameters in patients with primary Sj\u00f6gren\u2019s syndrome. Lupus 2017;26:690\u20137.","journal-title":"Lupus"},{"key":"2386_CR45","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S1542-0124(12)70043-5","volume":"4","author":"P Buchholz","year":"2006","unstructured":"Buchholz P, Steeds CS, Stern LS, Wiederkehr DP, Doyle JJ, Katz LM, et al. Utility assessment to measure the impact of dry eye disease. Ocul Surf. 2006;4:155\u201361.","journal-title":"Ocul Surf"},{"key":"2386_CR46","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/S0161-6420(03)00462-7","volume":"110","author":"RM Schiffman","year":"2003","unstructured":"Schiffman RM, Walt JG, Jacobsen G, Doyle JJ, Lebovics G, Sumner W. Utility assessment among patients with dry eye disease. Ophthalmology. 2003;110:1412\u20139.","journal-title":"Ophthalmology"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02386-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02386-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02386-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T04:10:37Z","timestamp":1693973437000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02386-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,19]]},"references-count":46,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["2386"],"URL":"https:\/\/doi.org\/10.1038\/s41433-023-02386-2","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,19]]},"assertion":[{"value":"4 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Research and Ethics Committees of the Royal Victoria Eye and Ear Hospital and The Royal College of Surgeons in Ireland granted ethical approval for this study and the study adhered to the tenets of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}}]}}